Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 25 results for "Emixustat Hydrochloride"

Stargardt Disease Drug Candidate Receives Orphan Drug Status
Monthly Prescribing Reference

Stargardt therapy receives orphan drug status

The FDA has granted orphan drug designation to Acucela's drug candidate emixustat hydrochloride (emixustat) for the treatment of Stargardt disease. The company is aiming to launch a proof-of-concept trial in 2018. We are very pleased to ... American Academy of Ophthalmology, 1 week ago
Stargardt Disease Drug Candidate Receives Orphan Drug Status Monthly Prescribing Reference, 1 week ago

BRIEF-Kubota Pharmaceutical Holdings unit gets orphan drug designation from FDA for treatment of stargardt disease

n"Jan 6 Kubota Pharmaceutical Holdings Co Ltd : * Says its unit Acucela Inc announced that the FDA (U.S. Food and Drug Administration) granted orphan drug designation to Acucela's leading drug candidate emixustat hydrochloride("emixustat") for the ...
 Reuters UK1 week ago Acucela Receives Orphan Drug Designation from the FDA for the Treatment of Stargardt Disease  4 Traders1 week ago
[x]  
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less